Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Arrhythmia; Delusion/attention disorders; Delusion/attention disorders; Exitus letalis/cause of death unknown; This is a spontaneous report from a contactable consumer downloaded from the Regulatory Authority [regulatory authority number DE-PEI-CADR2021015311] and [DE-PEI-2021005723]. A 95-year-old male patient received the 2nd dose of bnt162b2 (COMIRNATY, lot number: EM0477) via intramuscular on 30Jan2021 at 0.3 ml single for prophylactic vaccination. Medical history included ongoing coronary disease, ongoing chronic renal insufficiency, ongoing hypertension, ongoing type II diabetes mellitus, demyelinating disease (excl multiple sclerosis) which was unknown if ongoing. Concomitant medications were unknown. The patient previously received the 1st dose of bnt162b2 (COMIRNATY) on 09Jan2021 for Prophylactic vaccination. On 31Jan2021 the patient experienced attention disorders. On 03Feb2021 the patient experienced arrhythmia and cause of death unknown (reported as Exitus letalis). Outcome of the event Exitus letalis/cause of death unknown was fatal, of the other events was unknown. This report was serious - hospitalization. Institution considered that there is an inconsistent causal association to immunization for all three events. Sender Comment: Diab. meel Typ 2 with multiple complications, chron. renal failure, hypertension, coronary heart disease / Exitus letalis. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Unknown cause of death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166